EPIC-Knee study now available at ClinicalTrials.gov
Episurf Medical (NASDAQ: EPIS B) announces that the company’s clinical study EPIC-Knee: Episealer® Knee System IDE Clinical Study now has been published on ClinicalTrials.gov, the largest clinical trial database in the world. The study summary, giving information about the study design and outcome measures can be found at the link below: https://clinicaltrials.gov/ct2/show/NCT04000659?term=episurf&rank=1 The study is a randomised controlled trial with 180 subjects. The webpage will be continuously updated as the study progresses. For more information, please contact: Pål Ryfors,